Yoga for multiple sclerosis

Not Applicable

• Conditions: Health Condition 1: G30-G32- Other degenerative diseases of the nervous system

• Registration Number: CTRI/2021/07/034788
• Lead Sponsor: CCRY

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

A diagnosis of CDMS clinically defined multiple sclerosis using revised McDonald criteria 2010 2017 revision).

Relapsing-remitting multiple sclerosis

Minimum education with the ability to read and write

Consent to take part in the study

EDSS Expanded Disability Status Scale score between 0 and 6

On stable medication for at least 6 weeks

Exclusion Criteria

Any condition which the investigator feels that the patient is unsuitable.

Patients with Progressive course which resulted in early disability.

Patients of Expanded Disability Status Scale (EDSS) score 7 and above

Patients with Mini-Mental State Examination (MMSE) score more than or equal to 27.

Women with h/o of menorrhagia Dysfunctional uterine bleeding.

Neurological disorders (Epilepsy and Parkinsonism) and other neuro-degenerative disorders with MS complex.

Patients with substance dependence (except nicotine).

Pregnant and lactating women or women planning for pregnancy.

Patients with uncontrolled Type 2 Diabetes mellitus (FBS >126 mg/dl PPBS > 200 mg/dl.

Subjects on β-blockers thiazide diuretics corticosteroids HRT.

Subjects with Uncontrolled Hypertension (with or without medication).

Patients with concurrent Hepatic Dysfunction (defined as AST and/or ALT > 2 times of the upper normal limit) or Renal Dysfunction (defined as S.Creatinine > greater than ULL) uncontrolled Pulmonary Dysfunction (asthmatic and COPD subjects).

Patients with evidence of malignancy.

Patients with recent H/O fever.

Patients suffering from major systemic illness necessitating long term drug treatment (Rheumatoid arthritis Psycho-Neuroendocrinal disorders etc.)

Patients who have completed participation in any other clinical trial during the past six (06) months.

Practice of a structured yoga module in the past 3 months (three or more times per week) prior to the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To develop an Integrated Yoga Module for patients diagnosed with mild to moderate symptoms of relapsing remitting multiple sclerosis and who is ambulatory. <br/ ><br>To study its feasibility and acceptability in this population. <br/ ><br>Timepoint: Baseline,10 days,1 month <br/ ><br>

Secondary Outcome Measures

Name	Time	Method
ot applicableTimepoint: NA